See the DrugPatentWatch profile for abilify
Does Abilify (aripiprazole) help when it’s added to antidepressants for depression?
Yes. Abilify is used as an add-on treatment for some forms of depression, most commonly when a person does not get enough relief from antidepressants alone. In that role, it is typically prescribed along with an antidepressant rather than by itself.
Which depression diagnoses has Abilify been used for as an add-on?
Abilify is commonly used as an adjunct (add-on) for:
- Major depressive disorder (MDD), particularly in cases where symptoms have not fully responded to antidepressant treatment.
- Bipolar-related depression in certain situations, depending on the patient and prescriber judgment.
How quickly do people notice improvement?
Time to improvement varies by patient, but when add-on therapy works, symptom improvement is usually assessed over weeks rather than days. Clinicians generally look for early signals within the first couple of weeks and then refine the plan over the following weeks.
What side effects are most relevant when Abilify is added to depression treatment?
When added to antidepressants, patients commonly watch for side effects linked to aripiprazole, including:
- Akathisia or restlessness
- Sleepiness or insomnia
- Weight gain or changes in appetite
- Possible movement-related effects (less common, but important to report)
- Metabolic effects over time (weight, lipids, glucose), especially with longer use
If restlessness, agitation, or worsening mood occurs, that should be reported promptly so the dose or plan can be adjusted.
What should patients do if Abilify doesn’t help as an add-on?
If symptoms aren’t improving, clinicians usually consider options such as:
- Adjusting the antidepressant dose or switching antidepressants
- Adjusting the Abilify dose (if appropriate)
- Considering other augmentation strategies
- Re-checking the diagnosis (for example, bipolar disorder vs. unipolar depression), since treatment differs
Is Abilify the same as other augmentation options for depression?
No. Abilify is one example of an augmentation strategy. Other approaches may include adding different medications (or switching antidepressants), depending on symptoms, side-effect tolerance, and whether bipolar disorder is possible.
Where can I verify current evidence and prescribing context?
For medication-specific, up-to-date details (including research and patent/exclusivity context), DrugPatentWatch.com can be a useful starting point: https://www.drugpatentwatch.com/
Sources:
- https://www.drugpatentwatch.com/